Chemical Name,Chemical ID,CAS RN,Gene Symbol,Gene ID,Interaction,Interaction Actions,Reference Count,Organism Count
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,RBMS3,27303,"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,RBMS3,27303,"[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,RBMS3,27303,"[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,RBMS3,27303,"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,RBMS3,27303,"[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,RBMS3,27303,"[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",D015123,55097-80-8,RBMS3,27303,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RBMS3 mRNA",decreases^expression,1,1
8-Bromo Cyclic Adenosine Monophosphate,D015124,23583-48-4,RBMS3,27303,8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
abrine,C496492,,RBMS3,27303,abrine results in increased expression of RBMS3 mRNA,increases^expression,1,1
Acetaminophen,D000082,103-90-2,RBMS3,27303,Acetaminophen results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Aflatoxin B1,D016604,1162-65-8,RBMS3,27303,Aflatoxin B1 results in increased methylation of RBMS3 intron,increases^methylation,1,1
aflatoxin B2,C029753,22040-96-6,RBMS3,27303,aflatoxin B2 results in increased methylation of RBMS3 intron,increases^methylation,1,1
Air Pollutants,D000393,,RBMS3,27303,[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of RBMS3 mRNA,decreases^expression|increases^abundance,1,1
Antirheumatic Agents,D018501,,RBMS3,27303,Antirheumatic Agents results in increased expression of RBMS3 mRNA,increases^expression,1,1
aristolochic acid I,C000228,313-67-7,RBMS3,27303,aristolochic acid I results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Arsenic,D001151,7440-38-2,RBMS3,27303,[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBMS3 mRNA,increases^abundance|increases^expression,1,1
Auranofin,D001310,34031-32-8,RBMS3,27303,RBMS3 protein affects the susceptibility to Auranofin,affects^response to substance,1,1
Benzo(a)pyrene,D001564,50-32-8,RBMS3,27303,Benzo(a)pyrene affects the methylation of RBMS3 intron,affects^methylation,1,1
Benzo(a)pyrene,D001564,50-32-8,RBMS3,27303,Benzo(a)pyrene results in increased mutagenesis of RBMS3 gene,increases^mutagenesis,1,1
beta-methylcholine,C044887,7562-87-0,RBMS3,27303,beta-methylcholine affects the expression of RBMS3 mRNA,affects^expression,1,1
bisphenol A,C006780,80-05-7,RBMS3,27303,[bisphenol A co-treated with Fulvestrant] results in increased methylation of RBMS3 gene,affects^cotreatment|increases^methylation,1,1
bisphenol A,C006780,80-05-7,RBMS3,27303,bisphenol A results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
bisphenol A,C006780,80-05-7,RBMS3,27303,bisphenol A results in decreased methylation of RBMS3 gene,decreases^methylation,1,1
bisphenol A,C006780,80-05-7,RBMS3,27303,bisphenol A results in increased methylation of RBMS3 gene,increases^methylation,1,1
bisphenol S,C543008,,RBMS3,27303,bisphenol S results in decreased methylation of RBMS3 gene,decreases^methylation,1,1
butyraldehyde,C018475,123-72-8,RBMS3,27303,butyraldehyde results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
CGP 52608,C092451,87958-67-6,RBMS3,27303,CGP 52608 promotes the reaction [RORA protein binds to RBMS3 gene],affects^binding|increases^reaction,1,1
chromium hexavalent ion,C074702,18540-29-9,RBMS3,27303,[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RBMS3 mRNA,decreases^expression|increases^abundance,1,1
Cisplatin,D002945,15663-27-1,RBMS3,27303,[Cisplatin co-treated with jinfukang] results in decreased expression of RBMS3 mRNA,affects^cotreatment|decreases^expression,1,1
Cisplatin,D002945,15663-27-1,RBMS3,27303,Cisplatin results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
"cyclic 3',5'-uridine monophosphate",C045338,4004-57-3,RBMS3,27303,"RBMS3 protein binds to cyclic 3',5'-uridine monophosphate",affects^binding,1,1
Cyclosporine,D016572,59865-13-3,RBMS3,27303,Cyclosporine results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
dorsomorphin,C516138,,RBMS3,27303,"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
dorsomorphin,C516138,,RBMS3,27303,"[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
dorsomorphin,C516138,,RBMS3,27303,"[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
dorsomorphin,C516138,,RBMS3,27303,"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
dorsomorphin,C516138,,RBMS3,27303,"[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
dorsomorphin,C516138,,RBMS3,27303,"[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
Doxorubicin,D004317,23214-92-8,RBMS3,27303,Doxorubicin results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Estradiol,D004958,50-28-2,RBMS3,27303,Estradiol affects the expression of RBMS3 mRNA,affects^expression,1,1
Estradiol,D004958,50-28-2,RBMS3,27303,[Estradiol co-treated with Progesterone] results in increased expression of RBMS3 mRNA,affects^cotreatment|increases^expression,1,1
Fulvestrant,D000077267,129453-61-8,RBMS3,27303,[bisphenol A co-treated with Fulvestrant] results in increased methylation of RBMS3 gene,affects^cotreatment|increases^methylation,1,1
geldanamycin,C001277,30562-34-6,RBMS3,27303,geldanamycin results in increased expression of RBMS3 mRNA,increases^expression,1,1
jinfukang,C544151,,RBMS3,27303,[Cisplatin co-treated with jinfukang] results in decreased expression of RBMS3 mRNA,affects^cotreatment|decreases^expression,1,1
mercuric bromide,C042720,7789-47-1,RBMS3,27303,mercuric bromide results in increased expression of RBMS3 mRNA,increases^expression,1,1
mercuric bromide,C042720,7789-47-1,RBMS3,27303,"[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
Nickel,D009532,7440-02-0,RBMS3,27303,Nickel results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
nickel sulfate,C029938,7786-81-4,RBMS3,27303,nickel sulfate results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Okadaic Acid,D019319,78111-17-8,RBMS3,27303,Okadaic Acid results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Panobinostat,D000077767,,RBMS3,27303,"[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
Particulate Matter,D052638,,RBMS3,27303,[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of RBMS3 mRNA,decreases^expression|increases^abundance,1,1
Particulate Matter,D052638,,RBMS3,27303,[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of RBMS3 mRNA,increases^abundance|increases^expression,1,1
Phenylmercuric Acetate,D010662,62-38-4,RBMS3,27303,"[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
Phenylmercuric Acetate,D010662,62-38-4,RBMS3,27303,Phenylmercuric Acetate results in increased expression of RBMS3 mRNA,increases^expression,1,1
potassium chromate(VI),C027373,7789-00-6,RBMS3,27303,potassium chromate(VI) results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Progesterone,D011374,57-83-0,RBMS3,27303,[Estradiol co-treated with Progesterone] results in increased expression of RBMS3 mRNA,affects^cotreatment|increases^expression,1,1
sodium arsenite,C017947,13768-07-5,RBMS3,27303,sodium arsenite results in decreased expression of RBMS3 mRNA,decreases^expression,3,1
sodium arsenite,C017947,13768-07-5,RBMS3,27303,[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBMS3 mRNA,increases^abundance|increases^expression,1,1
sulforaphane,C016766,,RBMS3,27303,sulforaphane results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Sunitinib,D000077210,,RBMS3,27303,Sunitinib results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Thiram,D013893,137-26-8,RBMS3,27303,Thiram results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Tobacco Smoke Pollution,D014028,,RBMS3,27303,Tobacco Smoke Pollution results in decreased expression of RBMS3 mRNA,decreases^expression,2,1
Tretinoin,D014212,302-79-4,RBMS3,27303,Tretinoin results in increased expression of RBMS3 mRNA,increases^expression,2,1
trichostatin A,C012589,58880-19-6,RBMS3,27303,"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
trichostatin A,C012589,58880-19-6,RBMS3,27303,trichostatin A results in increased expression of RBMS3 mRNA,increases^expression,3,1
Triclosan,D014260,3380-34-5,RBMS3,27303,Triclosan results in decreased expression of RBMS3 mRNA,decreases^expression,1,1
Valproic Acid,D014635,99-66-1,RBMS3,27303,"[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
Valproic Acid,D014635,99-66-1,RBMS3,27303,Valproic Acid affects the expression of RBMS3 mRNA,affects^expression,1,1
Valproic Acid,D014635,99-66-1,RBMS3,27303,Valproic Acid results in decreased methylation of RBMS3 gene,decreases^methylation,1,1
Valproic Acid,D014635,99-66-1,RBMS3,27303,Valproic Acid results in increased expression of RBMS3 mRNA,increases^expression,6,1
Vehicle Emissions,D001335,,RBMS3,27303,[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of RBMS3 mRNA,increases^abundance|increases^expression,1,1
Vorinostat,D000077337,,RBMS3,27303,"[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA",affects^cotreatment|increases^expression,1,1
Vorinostat,D000077337,,RBMS3,27303,Vorinostat results in increased expression of RBMS3 mRNA,increases^expression,2,1
zinc chromate,C023616,13530-65-9,RBMS3,27303,[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RBMS3 mRNA,decreases^expression|increases^abundance,1,1
